Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2017 1
2018 1
2019 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Systemic lupus erythematosus.
Lisnevskaia L, Murphy G, Isenberg D. Lisnevskaia L, et al. Lancet. 2014 Nov 22;384(9957):1878-1888. doi: 10.1016/S0140-6736(14)60128-8. Epub 2014 May 31. Lancet. 2014. PMID: 24881804 Review.
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.
Bessette L, Chan J, Chow A, Lisnevskaia L, Richard N, Fournier PA, Liazoghli D, Girard T, Haaland D. Bessette L, et al. Among authors: lisnevskaia l. Rheumatol Ther. 2024 Jun;11(3):563-582. doi: 10.1007/s40744-024-00651-8. Epub 2024 Mar 11. Rheumatol Ther. 2024. PMID: 38467912 Free PMC article.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, Galos C, Roy P, Gruben D, Woolcott JC, Vaillancourt J, Sampalis JS, Keystone EC; Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators. Haraoui B, et al. Among authors: lisnevskaia l. Arthritis Care Res (Hoboken). 2023 Feb;75(2):240-251. doi: 10.1002/acr.24966. Epub 2022 Oct 10. Arthritis Care Res (Hoboken). 2023. PMID: 35678771 Free PMC article.
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
Baglaenko Y, Chang NH, Johnson SR, Hafiz W, Manion K, Ferri D, Noamani B, Bonilla D, Rusta-Sellehy S, Lisnevskaia L, Silverman E, Bookman A, Landolt-Marticorena C, Wither J. Baglaenko Y, et al. Among authors: lisnevskaia l. Arthritis Res Ther. 2018 Nov 29;20(1):264. doi: 10.1186/s13075-018-1752-3. Arthritis Res Ther. 2018. PMID: 30486869 Free PMC article.
Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.
Hafiz W, Nori R, Bregasi A, Noamani B, Bonilla D, Lisnevskaia L, Silverman E, Bookman AAM, Johnson SR, Landolt-Marticorena C, Wither J. Hafiz W, et al. Among authors: lisnevskaia l. Arthritis Res Ther. 2019 Nov 4;21(1):223. doi: 10.1186/s13075-019-2013-9. Arthritis Res Ther. 2019. PMID: 31685018 Free PMC article.